Covering: 2020 This review covers the literature published in 2020 for marine natural
products (MNPs), with 757 citations (747 for the period January to December 2020) referring …

Plant endophytes have been considered as novel sources of naturally occurring compounds
with various biological activities, including cytotoxic, antimicrobial, anti-inflammatory …

Fungal meroterpenoids are secondary metabolites from mixed terpene-biosynthetic origins.
Their intriguing chemical structural diversification and complexity, potential bioactivities, and …

Meroterpenoids are natural products synthesized by unicellular organisms such as bacteria
and multicellular organisms such as fungi, plants, and animals, including those of marine …

Meroterpenoids are secondary metabolites formed due to mixed biosynthetic pathways
which are produced in part from a terpenoid co-substrate. These mixed biosynthetically …

Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …

The current 2019–2021 marine pharmacology literature review provides a continuation of
previous reviews covering the period 1998 to 2018. Preclinical marine pharmacology …

The growing threat arises due to diseases such as cancer and the infections around the
world leading to a critical requirement for novel and constructive compounds with unique …

In its original definition, meroterpenoids refer to substances of mixed biosynthesis including
a terpenoid part. The number of compounds fulfilling this criterion is huge, and almost from …

Dhilirane-type meroterpenoids (DMs) featuring a 6/6/6/5/5 ring system represent a rare
group of fungal meroterpenoids. To date, merely 11 DMs have been isolated or derived …